BD 3 jun 2026 Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics - PR Newswire
BD 7 may 2026 BD uplifts FY26 revenue outlook based on steady portfolio performance - Medical Device Network
BD 5 may 2026 Analyst Reiterates Buy on Waters as Pharma Demand, BD Synergies and Earnings Outlook Drive Positive Risk-Reward - TipRanks
BD 28 abr 2026 BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech - Manufacturing Chemist
BD 27 abr 2026 BD, Suttons Creek Partner to Support Pharma & Biotech Companies Developing Combination Products - Contract Pharma
BD 8 abr 2026 BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union - Becton Dickinson
BD 8 abr 2026 FDA clears Onclarity HPV self-collection kit, approves BD Onclarity HPV Assay for cervical cancer screening - Contemporary OB/GYN
BD 24 feb 2026 Waters Merger With BD Unit Shifts Focus Toward Diagnostics And Valuation - Yahoo Finance
BD 9 feb 2026 BD Reports First Quarter Fiscal 2026 Financial Results :: Becton, Dickinson and Company (BDX) - Becton Dickinson
BD 9 feb 2026 Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses - Contract Pharma
BD 28 ene 2026 BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
BD 27 ene 2026 BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business - Becton Dickinson
BD 19 ene 2026 BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026 - BD Newsroom
BD 23 jul 2025 BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - BD Newsroom